GLP-1 Agonists Show Promise for Sickle Cell Patients with Type 2 Diabetes

Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis. Authors: Nguefang GL, Boateng S, Gyabaah S, Issaka Y, Konlack JG, Landa EL, Eze E, Njei B Journal: Orphanet jo…